Moors & Cabot, Inc. Scopus Bio Pharma Inc. Transaction History

Moors & Cabot, Inc.

  • $1.85 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022
SELL
$0.36 - $0.74 $5,220 - $10,730
-14,500 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$0.6 - $1.7 $8,700 - $24,650
14,500 New
14,500 $10,000

Others Institutions Holding SCPS

# of Institutions
1
Shares Held
100
Call Options Held
0
Put Options Held
0
View Full List

About Scopus BioPharma Inc.

SCPS Quotes by TradingView
  • Ticker SCPS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,094,300
  • Description
  • Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) i...
More about SCPS
Track This Portfolio

Track Moors & Cabot, Inc. Portfolio

Follow Moors & Cabot, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email